Sep 292011
 

Kip Ludwig, who was recently appointed as program director in repair and plasticity at the NIH National Institute for Neurological Disorders and Stroke, will deliver the keynote address at the 11th annual Neurotech Leaders Forum, which will take place in San Francisco on October 17-18, 2011. Ludwig will offer attendees his views on his new role with the NIH and how it impacts the neurotechnology industry.

Ludwig received his Ph.D. in Bioengineering at the University of Michigan, followed by post-doctoral work at the same institution. More recently, Ludwig worked in industry at CVRx as a research scientist, where he and his team conceived, developed and demonstrated the chronic efficacy of a next-generation neural stimulation electrode for reducing blood pressure in both pre-clinical and clinical trials.

The 2011 event will also feature an in-depth session on reimbursement issues affecting neurotechnology manufacturers in light of new health care reform legislation.

Venture capital professionals Heath Lukatch of Novo Ventures, Paul Grand of RCT BioVentures, Mikhail Shapiro, formerly of Third Rock Ventures, and Jonas Hansson of HealthCap in Sweden will participate. Other speakers include Don Deyo, vice president of R&D at Medtronic Neuromodulation, medical device reimbursement expert Tom Hughes, and Victor Pikov of Huntington Medical Research Institutes.

The 2011 event will feature a first-ever Consumer Neurotech Conference on October 18, the second day of the event. The full-day meeting will include sessions on neuromarketing, gaming, training, and cognitive enhancement applications of neurotechnology. Companies represented on the agenda include EmSense Corp., NeuroSky, Inc., and Technology Partners. Victor Pikov will also speak on neural interface lifestyle issues.

For more information on the 2011 Neurotech Leaders Forum, including sponsorship opportunities, call 415 546 1259.

Sorry, the comment form is closed at this time.